Business Angels des Grandes Ecoles
VC Fund
Paris, France
Business Angels des Grandes Ecoles is a VC fund in Paris focused on Health Care and Medical. Created in 2004, the "Business Angels of Grandes Ecoles" association (BADGE) is one of the leading Business Angels networks in France. Their members are, for many, from engineering or management schools, but many other skills and experiences are represented.
- Total investments:
- 20
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Business Angels des Grandes Ecoles invests in
Stages Business Angels des Grandes Ecoles invests in
Countries Business Angels des Grandes Ecoles invests in
Investment Focus
Industry
- Health Care 4 (20%)
- Medical 3 (15%)
- Biotechnology 3 (15%)
- Medical Device 3 (15%)
- Security 2 (10%)
Stage
- Seed 12 (60%)
- Angel 2 (10%)
- Series A 2 (10%)
- Funding Round 2 (10%)
Country
- France 16 (80%)
- United States 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cyclair
|
Cyclair creates technological solutions that maintain crop protection and existing yields while enabling a remarkable decrease in the volumes of chemical inputs. Our deals are made to be financially beneficial. It is our responsibility to balance economic and environmental performance. | $2.3M / Seed / Dec 11, 2023 | |
Inspeere
|
Inspeere provides a distributed IT backup solution for enterprises and organizations at a flat charge regardless of data volume. The solution developed by Inspeere is the result of several years of research at the I3S Laboratory, UMR CNRS. They have created a technological alternative, independent of construction so that each data saved by Inspeereremains under the control of its owner whatever happens. | $653.6K / Seed / Nov 30, 2023 | |
Losonnante
|
Losonnante has created a discrete bone conduction listening object, a discrete sound bubble that does not induce sound conflicts and can be deployed in noisy surroundings. The device provides a basic surface on which to rest your elbows, and the music changes slightly based on the position of your hands on your ears, allowing everyone to discoverthe most comfortable listening posture. | $976.9K / Angel / Nov 15, 2023 | |
SeaBeLife
|
SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules. | $1.3M / Seed / Sep 26, 2023 | |
MAG4HEALTH
|
MAG4HEALTH is a Developer of magnetoencephalography. Magnetoencephalography (MEG) are brain imaging technologies that display neural activity. | $5.7M / Seed / May 23, 2023 | |
MOTEN Technologies
|
MOTEN Technologies provides muscle sensors technology, analysis platform, and personalized support services. They also provide data processing, physical assistance, and analysis software services. | $976.7K / Seed / Oct 13, 2022 | |
Sensivic
|
Sensivic created a technique for audio detection. Their services include Intelligent audio detection, smart audio detection, artificial intelligence, machine learning, edge computing, detectors, applications, firmware, OEMs, security, safety, video protection, startup, innovation, and video surveillance. | $1.7M / Seed / Jun 15, 2022 | |
WATTPARK
|
WattPark is a charging point solution for the automobile industry. They offer reservable and monetizable charging stations that allow users to choose precise locations and associated services through bluetooth, enabling automobile clients with parking devices and charging solutions that work in areas without network coverage or internet. | $1.7M / Seed / Nov 15, 2021 | |
PEP-Therapy
|
PEP-Therapy is a biotechnology company developing first-in-class peptides as targeted therapies for severe diseases, with an initial focus on cancer. PEP-Therapy develops Cell Penetrating and Interfering Peptides (CP&IP) for the intracellular delivery of targeted therapies. These active compounds penetrate cells and block relevantintracellular protein-protein interactions, thus inhibiting key pathological mechanisms. | $1.9M / Series A / Jul 19, 2021 | |
|
PEP-Therapy
|
PEP-Therapy is a biotechnology company developing first-in-class peptides as targeted therapies for severe diseases, with an initial focus on cancer. PEP-Therapy develops Cell Penetrating and Interfering Peptides (CP&IP) for the intracellular delivery of targeted therapies. These active compounds penetrate cells and block relevantintracellular protein-protein interactions, thus inhibiting key pathological mechanisms. | $3.3M / Series A / Apr 22, 2021 | |
| See all 20 investments → | |||
Co-Investors
Les Business Angels des Grandes Écoles
21 deals together
Angels Santé
7 deals together
Paris Business Angels
5 deals together
Bpifrance
4 deals together
Anaxago
3 deals together
Femmes Business Angels
3 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Business Angels des Grandes Ecoles invest in?
Business Angels des Grandes Ecoles invests primarily in Health Care, Medical and Biotechnology startups, most often at Seed and Angel stage. Most of the 20 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Business Angels des Grandes Ecoles last invest?
The most recent investment recorded for Business Angels des Grandes Ecoles closed in Dec 2023. Shizune tracks 20 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
